Adverse events of antibody–drug conjugates on the ocular surface in cancer therapy

Antibody–drug conjugates consist of a monoclonal antibody attached to a cytotoxic therapeutic molecule by a connector. This association allows a highly specific therapy, which increases their effectiveness and decreases their potential toxicity. This new therapy emerged approximately 20 years ago; s...

Descripción completa

Detalles Bibliográficos
Autores principales: Domínguez-Llamas, Sandra, Caro-Magdaleno, Manuel, Mataix-Albert, Beatriz, Avilés-Prieto, Javier, Romero-Barranca, Isabel, Rodríguez-de-la-Rúa, Enrique
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10514170/
https://www.ncbi.nlm.nih.gov/pubmed/37454027
http://dx.doi.org/10.1007/s12094-023-03261-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10514170/
https://www.ncbi.nlm.nih.gov/pubmed/37454027
http://dx.doi.org/10.1007/s12094-023-03261-y

Ejemplares similares